MENU

Namrata (Neena) Vijayvergia, MD

Department of Hematology/Oncology
Namrata (Neena) Vijayvergia, MD

Clinical Locations

Primary Location

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111

About

Assistant Chief, Gastrointestinal Medical Oncology

Assistant Professor, Department of Hematology/Oncology

TRDG Member, Colorectal and SI Cancer; Esophagus, Pancreas, and Liver Cancer

Medical Director, Medical Oncology, Fox Chase Cancer Center Partners

Specialties

Colorectal Cancer;  Esophageal Cancer;  Liver, Gall Bladder & Bile Duct Cancer;  Neuroendocrine Tumors;  Pancreatic Cancer;  Stomach Cancer

Treatment Philosophy

Coming from a family of 12 doctors, I wanted to be one for as long as I can remember. After graduating from medical school in India, I pursued Internal Medicine training at Temple University Hospital in Philadelphia, where I also served as a chief medical resident. During that time I became interested in oncology and clinical research. I recently completed my fellowship in hematology/oncology at Temple/Fox Chase Cancer Center and have been fortunate enough to stay on as faculty. Early in my training, I realized that I wanted to dedicate my career to help discover new therapies for patients with gastrointestinal cancers, with a particular focus on pancreatic and neuroendocrine malignancies. We have made significant progress but a lot still needs to be done.

... Expand

Education, Training & Credentials

Educational Background

  • Fellow, Hematology/Oncology, Fox Chase Cancer Center, Philadelphia, PA, 2012-2015
  • Resident, Temple University Hospital, Philadelphia, PA, 2008-2011
  • Bachelor of Medicine and Bachelor of Surgery (MBBS), Jawaharlal Nehru Medical College, University of Rajasthan, Ajmer, India, 2007

Certifications

  • American Board of Internal Medicine

Memberships

  • American Society of Clinical Oncology
  • American Society of Hematology
  • North American Neuroendocrine Tumor Society
  • American Medical Association
  • Indian Medical Association
Research Profile

Research Interests

Neuroendocrine Tumors
Pancreatic Cancer
Outcomes Research
Publications

Selected Publications

Vijayvergia, N., Denlinger, C., Survivorship in Non-Small Cell Lung Cancer:Challenges Faced and Steps Forward. Manuscript submitted to JNCCN. 2015  PubMed

Vijayvergia, N., Dotan, E., Cohen, S.J., Predictors of long-term survival with metastatic pancreatic cancer (mPC) in the gemcitabine era: The Fox Chase Cancer Center experience. Manuscript submitted to Cancer. 2015  PubMed

Matthews, E., Zhou, L., Vijayvergia, N., El-Deiry, W., A Multiplexed Marker-based Algorithm for Diagnosis of Carcinoma of Unknown Primary Using Circulating Tumor Cells, Poster accepted for presentation at AACR 2015. 2014 

Vijayvergia, N., Cohen, S.J., Predictors of long-term survival with metastatic pancreatic cancer (mPC) in the gemcitabine era: The Fox Chase Cancer Center experience. J Clin Oncol 33, 2015 (suppl 3; abstr 253). 2014

Vijayvergia, N., Engstrom, P.F., Molecular profiling of advanced stage Neuro Endocrine Tumors (NETs): The Fox Chase Cancer Center (FCCC) experience. Poster presented at NANETS annual symposium 2014 and GI ASCO Symposium 2015 (JClin Oncol 33, 2015 (suppl 3; abstr 245)

Vijayvergia N, Mehra R. Clinical challenges in targeting anaplastic lymphoma kinase in advanced non-small cell lung cancer. Cancer Chemother Pharmacol. 2014 Sep;74(3):437-46

Related News

Namrata (Neena) Vijayvergia, MD

Junior Investigators Win Awards for Pilot Projects

PHILADELPHIA (January 18, 2017) – Fox Chase Cancer Center is pleased to announce the results of its American Cancer Society Institutional Research Grant (IRG) Pilot Project Competition for Junior Investigators, Yibin Yang, PhD, Matthew R. Zibelman, MD, and Namrata (Neena) Vijayvergia, MD.
Keep Reading

Fox Chase Cancer Center Offers Tips to Reduce Your Risk for Cancer

PHILADELPHIA (December 1, 2016) – The New Year is just weeks away. Empower your 2017 by making a resolution to reduce your risk for cancer. Your chances of developing cancer are affected by the lifestyle choices you make. Take steps this coming year to adopt positive changes and get regular recommended cancer screenings.

Keep Reading
Namrata Vijayvergia, MD

Fox Chase Cancer Center Seeks to Educate Individuals on Pancreatic Cancer and Its Risk Factors

PHILADELPHIA (August 1, 2016) – This month, Fox Chase Cancer Center seeks to raise awareness about pancreatic cancer and risk factors for the disease.

Keep Reading
Researchers Developing New Targeted and Immune Therapies for Colorectal Cancer Molecular Subtypes

Researchers Developing New Targeted and Immune Therapies for Colorectal Cancer Molecular Subtypes

CHICAGO (May 27, 2015) — Researchers from Fox Chase Cancer Center in Philadelphia recently collaborated with Caris Life Sciences® to conduct three separate studies related to precision medicine, particularly in colorectal cancers. These findings will be highlighted at the upcoming 2015 American Society of Clinical Oncology Annual Meeting.

Keep Reading

Related Blog Posts

New Phase 2 Clinical Trial for Patients with Metastatic High Grade Neuroendocrine Tumors

There is a national unmet need for clinical trials targeting patients with this rare malignancy. The study is one of a kind in the nation and is designed to help patients with high grade neuroendocrine tumors specifically.

Keep Reading

Fox Chase Announces the Promotion of Namrata (Neena) Vijayvergia, MD, to Medical Director, Medical Oncology, Fox Chase Cancer Center Partners

Dr. Vijayvergia has been a faculty member of Fox Chase since 2015. She also serves as assistant professor in the department of hematology/oncology as well as the assistant chief of gastrointestinal medical oncology.

Keep Reading